Previous 10 | Next 10 |
Pacira BioSciences, Inc. (PCRX) Q1 2020 Results Earnings Conference Call May 07, 2020, 08:30 AM ET Company Participants Susan Mesco - Head of Investor Relations David Stack - Chairman and Chief Executive Officer Charles Reinhart III - Chief Financial Officer Conference Call Pa...
Image source: The Motley Fool. Pacira BioSciences, Inc. (NASDAQ: PCRX) Q1 2020 Earnings Call May 8, 2020 , 8:30 p.m. ET Operator Continue reading
Pacira Pharmaceuticals (NASDAQ: PCRX ): Q1 Non-GAAP EPS of $0.53 beats by $0.23 ; GAAP EPS of $0.19 beats by $0.10 . More news on: Pacira BioSciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
-- Total revenues increased 16 percent over prior year first quarter -- -- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., May 07, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today re...
-- Veteran Industry Executive and Anesthesiologist Brings Significant Clinical and Commercial Experience in Pain Management -- PARSIPPANY, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), a leading provider of innovative non-opioid pain management options...
PARSIPPANY, N.J., April 30, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on Thursday, May 7, 2020. Following the release, the company will host a live conference ca...
The FDA has accepted for review a marketing application from privately held Innocoll Holdings Limited seeking approval of Xaracoll (bupivacaine hydrochloride collagen-matrix implants) for the management of postsurgical pain after inguinal (groin) hernia surgery. The agency's action date is...
Ascendis Pharma (NASDAQ: ASND ) initiated with Outperform rating with a $199 (97% upside) price target at Oppenheimer. More news on: Ascendis Pharma A/S, Livongo Health, Inc., Cardinal Health, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Image source: The Motley Fool. Pacira BioSciences, Inc. (NASDAQ: PCRX) Q4 2019 Earnings Call Feb. 20, 2020 , 8:30 a.m. ET Operator Continue reading
PARSIPPANY, N.J., March 09, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 Barclays Global Healthcare Conference at 9:00 AM ET on Thursday, March 12, 2020. Live audio of the event can be accessed by visiting the “E...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results after the close of the U.S. markets on Tuesday July 30, 2024. Following the release, the company will host a live conference call and webc...
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...